Products Antibodies Polyclonal Antibodies [KO Validated] Anti-PML Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - P29590
[KO Validated] Anti-PML Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - P29590

Polyclonal Antibodies

[KO Validated] Anti-PML Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - P29590

Item Number : CM0017817

Price varies based on specs and customizations


Application
WB, IHC-P, ELISA
Cross Reactivity
Human
Protein Weight
98kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name [KO Validated] PML Rabbit pAb
Remarks/Alias MYL; RNF71; PP8675; TRIM19; ML
Species Human
GeneID 5371
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 300-600 of human PML (NP_150241.2)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IHC-P, ELISA
Cross Reactivity Human
SWISS P29590
Protein Weight 98kDa
Shipping Ice bag

Biological Background: PML Function and Localization

  • Encoded by the PML gene, Protein PML is also known as E3 SUMO-protein ligase PML, Promyelocytic leukemia protein, RING finger protein 71, and Tripartite motif-containing protein 19 (TRIM19). It belongs to the TRIM family and contains a RING finger domain, B-box, coiled-coil region, and a C-terminal domain subject to alternative splicing, generating multiple isoforms with distinct functions.
  • Acts as the essential scaffold protein of PML nuclear bodies (PML-NBs), dynamic subnuclear structures that regulate tumor suppression, transcriptional control, apoptosis, senescence, DNA damage responses, and antiviral defense by recruiting and modulating numerous partner proteins via SUMO-mediated interactions.
  • Inhibits EIF4E-mediated mRNA nuclear export by reducing EIF4E binding affinity for the 5' m7G cap of target mRNAs, thereby controlling gene expression at the post-transcriptional level. Related references: PMID:11500381 PMID:11575918 PMID:18391071
  • Functions as an E3 SUMO-protein ligase that catalyzes SUMO conjugation to substrate proteins, including viral immediate-early proteins, and exhibits robust isoform-dependent sumoylation activity (particularly isoforms PML-3 and PML-6). Related references: PMID:20972456 PMID:28250117
  • Multiple isoforms (PML-1 to PML-14) display distinct subcellular localizations: nuclear isoforms (e.g., PML-4) localize to PML-NBs and nucleoplasm, while cytoplasmic isoforms (e.g., PML-14) associate with the endoplasmic reticulum and early endosome membranes, enabling context-dependent signaling in TGF-beta and other pathways.
  • Key post-translational modifications include SUMOylation (essential for PML-NB formation), phosphorylation, and acetylation, which modulate its stability, interactions, and tumor-suppressive functions.
  • Exhibits broad antiviral activity against both DNA and RNA viruses (e.g., herpesviruses, rabies, influenza, HCV) through isoform-specific mechanisms such as viral capsid sequestration, inhibition of viral mRNA/protein synthesis, and induction of apoptosis in infected cells.
  • Plays a pivotal role in cellular senescence and apoptosis by positively regulating p53/TP53 stability and activity, and by repressing TBX2 transcription via the RBL2/E2F4 complex, linking PML to permanent growth arrest.

Experimental Guidance and Technical Tips

  • The immunogen corresponds to amino acids 300-600 of human PML (isoform 1), a central region expected to detect multiple isoforms; consider verifying reactivity in your specific model system due to alternative splicing.
  • For Western blot, the predicted molecular weight is approximately 98 kDa, but isoforms and SUMOylated species may appear at higher molecular weights; using a high-quality protein ladder and optimizing transfer conditions is recommended.
  • This antibody is validated for KO (knockout) confirmation; ensure to include appropriate KO control lysates in WB experiments to confirm band specificity.
  • For IHC-P, antigen retrieval conditions (e.g., citrate buffer pH 6.0 or EDTA pH 9.0) should be optimized, and it is advisable to validate staining patterns against known PML-NB distribution in tissues.
  • In ELISA applications, consider using the recombinant immunogen as a positive control to establish sensitivity and linear range.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers and research laboratories with streamlined access to a comprehensive portfolio of IVD raw materials, including validated antibody pairs, optimized monoclonal and polyclonal antibodies, bulk ancillary reagents, and specialized sourcing for rare targets. For PML-focused oncology and virology research, we supply high-quality antibodies and related reagents to support assay development and biomarker studies, serving as a reliable bridge from concept to clinical application.

View more faqs for this product

Product Datasheet

[KO Validated] Anti-PML Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - P29590


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!